Article
SIG Spotlight: Hospital Medicine Fellowships
May 1, 2024
Being a new kid on the block can be daunting, even in the world of SHM’s Special Interest Groups (SIGs). Longer-standing SIGs have board protocols, event schedules, and a history to rely on when...
Article
Can Pentoxifylline Improve Healing of Lower Extremity Ulcers?
May 1, 2024
Case The patient, Mr. D, has been experiencing swelling in his legs for several years, and seven months prior, he noticed that his skin had started to develop ulcers. He has class 3 obesity, type 2...
Article
Shared Experiences Make Us Stronger Together
April 1, 2024
Dr. Kris Rehm, outgoing SHM president, and Dr. Rachel Thompson, immediate past president, continued The Prez Room series of discussions with members. As I reflect on our time this year, I want to...
Article
Coding Corner: A Critical Opportunity
April 1, 2024
A 17-year-old with a history of major depressive disorder who is new to the hospitalist service is being transferred out of the pediatric intensive care unit (PICU) after an intentional Benadryl...
Article
Torsemide or Furosemide After Discharge in Patients Hospitalized with HF
April 1, 2024
Clinical question: Is there a mortality difference in patients discharged on torsemide versus furosemide after heart failure hospitalization? Background: Torsemide has been thought to be superior to...
Article
Semaglutide in Patients with HFpEF and Obesity
April 1, 2024
Clinical question: Does treatment with semaglutide lead to a reduction in symptoms and physical limitations and improve exercise function in patients with heart failure with preserved ejection...
Article
VTEs and Their Effects on Patients with AE-COPD
April 1, 2024
Clinical question: How common are venous thromboembolisms (VTEs) in patients presenting with acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and what is the effect on prognosis,...
Article
Risk and Benefit of Secondary Prevention with Aspirin Versus P2Y12 Inhibitor in CAD Patients
April 1, 2024
Clinical question: In patients with coronary artery disease (CAD), what is the difference in risk and benefit between secondary prevention with aspirin (ASA) versus a P2Y12 inhibitor? Background:...
Article
Cefepime Versus Piperacillin-tazobactam in Adults Hospitalized with Acute Infection
April 1, 2024
Clinical question: Are there increased adverse outcomes with the utilization of cefepime or piperacillin-tazobactam? Background: Hospitalists frequently prescribe cefepime or piperacillin-tazobactam...
Article
Time to Benefit of SGLT-2 Inhibitors Among Patients with HF
April 1, 2024
Clinical question: What is the time to benefit for patients with heart failure (HF) and prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor? Background: SGLT-2 inhibitors are an effective...